Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,290 | 5,365 | 2,656 | 3,631 | 5,466 |
| TOTAL | $3,622 | $5,824 | $2,862 | $3,832 | $5,737 |
| Non-Current Assets | |||||
| PPE Net | 187 | 207 | 228 | 248 | 269 |
| Other Non-Current Assets | 0 | 0 | 0 | 18 | 27 |
| TOTAL | $187 | $207 | $228 | $266 | $296 |
| Total Assets | $3,809 | $6,031 | $3,090 | $4,098 | $6,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 491 | 542 | 521 | 511 | 702 |
| Accrued Expenses | 1,568 | 2,217 | 2,002 | 1,754 | 1,901 |
| TOTAL | $2,059 | $2,759 | $2,523 | $2,265 | $2,603 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,059 | $2,759 | $2,523 | $2,265 | $2,603 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 1 | 1 | 0 | 0 |
| Retained earnings | -84,184 | -82,691 | -80,790 | -78,551 | -76,549 |
| TOTAL | $1,750 | $3,272 | $567 | $1,833 | $3,430 |
| Total Liabilities And Equity | $3,809 | $6,031 | $3,090 | $4,098 | $6,033 |